Related Experiment Videos
Urologic experience with the Dornier multipurpose lithotripter MPL 9000.
Summary
The Dornier multipurpose lithotripter MPL 9000 effectively treated kidney stones in over 500 patients, achieving a 73.1% stone-free rate. Many treatments were performed without anesthesia, and no major complications were observed.
Area of Science:
- Urology
- Medical Devices
- Nephrology
Background:
- Kidney stones (renal calculi) are a common condition requiring effective treatment.
- Extracorporeal shock wave lithotripsy (ESWL) is a primary modality for stone management.
- The Dornier multipurpose lithotripter MPL 9000 is a specific device used for ESWL.
Purpose of the Study:
- To evaluate the effectiveness and safety of the Dornier multipurpose lithotripter MPL 9000 for treating renal and ureteral stones.
- To assess stone-free rates and complication profiles associated with MPL 9000 treatments.
- To analyze the utilization of anesthesia and analgesia during ESWL procedures.
Main Methods:
- A retrospective analysis of 603 stones in 502 patients treated with the Dornier MPL 9000 from March 1988 to October 1989.
- Data collection included stone location, characteristics (e.g., radiolucency), treatment details, anesthesia use, and follow-up outcomes.
- Stone-free status and residual fragment locations were assessed at 3-month follow-up.
Main Results:
- A 73.1% stone-free rate was achieved after 3 months.
- Most stones treated were in the calix (66%) and renal pelvis (29.6%).
- A significant portion of treatments (58.6%) were performed without analgesia or anesthesia; no major complications were reported. Difficulties were noted in localizing ureteral stones.
Conclusions:
- The Dornier MPL 9000 demonstrates effectiveness in treating renal stones.
- The device is well-tolerated, with a high percentage of treatments performed without anesthesia.
- While effective for renal stones, challenges in ureteral stone localization were identified.